Aiming for a Better Understanding and Management of Cancer-Related Fatigue

E.C.W. Neefjes; M.J.D.L. van der Vorst; S. Buskermolen; H.M.W. Verheul

doi:https://doi.org/10.1634/theoncologist.2013-0076

Aiming for a Better Understanding and Management of Cancer-Related Fatigue

E.C.W. Neefjes, M.J.D.L. van der Vorst, S. Buskermolen, H.M.W. Verheul

Research output: Contribution to journal › Article › Academic › peer-review

67 Citations (Scopus)

Abstract

Cancer-related fatigue (CRF) is a serious symptom of patients with cancer and deteriorates their daily quality of life. Whereas fatigue is a common problem in the general population, with a prevalence of about 30%, up to 99% of patients with cancer have fatigue of more intense severity. CRF is directly related to the biology of cancer, but it can also be caused by anticancer treatment. We reviewed current evidence about the potential pathophysiological mechanisms causing CRF. Clinical methods to determine the presence and severity of CRF and potential treatment options to reduce CRF will be discussed. After reading this review, the reader will have knowledge of the current understanding of CRF and will be able to give evidence-based advice to patients with CRF

Original language	Undefined/Unknown
Pages (from-to)	1135-1143
Journal	The Oncologist
Volume	18
Issue number	10
DOIs	https://doi.org/10.1634/theoncologist.2013-0076
Publication status	Published - 2013

Access to Document

https://doi.org/10.1634/theoncologist.2013-0076

Cite this

@article{9d4913ce889a483f8c4f12796e912c2d,

title = "Aiming for a Better Understanding and Management of Cancer-Related Fatigue",

abstract = "Cancer-related fatigue (CRF) is a serious symptom of patients with cancer and deteriorates their daily quality of life. Whereas fatigue is a common problem in the general population, with a prevalence of about 30%, up to 99% of patients with cancer have fatigue of more intense severity. CRF is directly related to the biology of cancer, but it can also be caused by anticancer treatment. We reviewed current evidence about the potential pathophysiological mechanisms causing CRF. Clinical methods to determine the presence and severity of CRF and potential treatment options to reduce CRF will be discussed. After reading this review, the reader will have knowledge of the current understanding of CRF and will be able to give evidence-based advice to patients with CRF",

author = "E.C.W. Neefjes and {van der Vorst}, M.J.D.L. and S. Buskermolen and H.M.W. Verheul",

year = "2013",

doi = "https://doi.org/10.1634/theoncologist.2013-0076",

language = "Undefined/Unknown",

volume = "18",

pages = "1135--1143",

journal = "The Oncologist",

issn = "1083-7159",

publisher = "AlphaMed Press",

number = "10",

}

TY - JOUR

T1 - Aiming for a Better Understanding and Management of Cancer-Related Fatigue

AU - Neefjes, E.C.W.

AU - van der Vorst, M.J.D.L.

AU - Buskermolen, S.

AU - Verheul, H.M.W.

PY - 2013

Y1 - 2013

N2 - Cancer-related fatigue (CRF) is a serious symptom of patients with cancer and deteriorates their daily quality of life. Whereas fatigue is a common problem in the general population, with a prevalence of about 30%, up to 99% of patients with cancer have fatigue of more intense severity. CRF is directly related to the biology of cancer, but it can also be caused by anticancer treatment. We reviewed current evidence about the potential pathophysiological mechanisms causing CRF. Clinical methods to determine the presence and severity of CRF and potential treatment options to reduce CRF will be discussed. After reading this review, the reader will have knowledge of the current understanding of CRF and will be able to give evidence-based advice to patients with CRF

AB - Cancer-related fatigue (CRF) is a serious symptom of patients with cancer and deteriorates their daily quality of life. Whereas fatigue is a common problem in the general population, with a prevalence of about 30%, up to 99% of patients with cancer have fatigue of more intense severity. CRF is directly related to the biology of cancer, but it can also be caused by anticancer treatment. We reviewed current evidence about the potential pathophysiological mechanisms causing CRF. Clinical methods to determine the presence and severity of CRF and potential treatment options to reduce CRF will be discussed. After reading this review, the reader will have knowledge of the current understanding of CRF and will be able to give evidence-based advice to patients with CRF

U2 - https://doi.org/10.1634/theoncologist.2013-0076

DO - https://doi.org/10.1634/theoncologist.2013-0076

M3 - Article

C2 - 24037979

SN - 1083-7159

VL - 18

SP - 1135

EP - 1143

JO - The Oncologist

JF - The Oncologist

IS - 10

ER -